2Zieglcer TR,Pierce GF, Herndon DN, eds. Growth factors and wound healing:Basic science and potential clincal applications. New York: Springer-Verlag, 1997,3-6.
3Basilico C,Moscatelli D. The bFGF family of growth factots and oncogenes. Adv Cancer Res. 1992.59: 115- 165.
4Ku PT,D'Amore PA. Regulation of fibroblast growth factor (bFGF) gene and protein expression following its release from sublethally injured endothelialcells. J Cell Biochem, 1995,58:328-343.
5Robinson CJ. Growth factor: Therapeutic advance in wound healing. Ann Med,1993, 25:535-538.
6Cohen K. An overview of wound healing biology, In:Zieglcer TR, Pierce GF, Herndon DN, Eds. Growth Factors and Wound Healing; Springer; New York.1997;3-6.
7Slavin J. Fibroblast growth factors: at the heart of angiogenesis. Cell Bio Int,1995,431-444.
6D'Ambrosio D, Iellem A, Colantonio L, Clissi B, Pardi R, Sinigaglia F. Localization of Th-cell subsets in inflammation: differential thresholds for extravasation of Thl and Th2 cells. Immunol Today, 2000, 21 (4) : 183-186.
7Zhang XW, Wang Y, Liu Q, Thorlacius H.Redundant function of macrophage inflammatory protein-2 and KC in tumor necrosis factor-alpha-induced extravasation of neutrophils in vivo. Eur J Pharmacol, 2001 Sep 21,427 (3): 277-283.
8Leversedge FJ,Srinivasan RC.Management of soft-tissue injuries in distal radius fractures.Hand Clin,2012;28(2)∶225-233.
9Chen J,Hu W,Qu YQ,et al.Evaluation of the pharmacodynamics and pharmacokinetics of brucine following transdermal administration.Fitoterapia,2013;86∶193-201.
10Gierer P,Laue F,Hoffmann JN,et al.Antithrombin reduces inflammation and microcirculatory perfusion failure in closed soft-tissue injury and endotoxemia.Crit Care Med,2013;41(3)∶867-873.
